Teva Pharmaceutical Industries Limited
TEVADrug Manufacturers - Specialty & Generic
$41.47+3.75%As of Oct 29vs prior close
- Market cap
- $48.4B
- P/E (TTM)
- 68.4×
- From 52W high
- −0.07%
- EPS (LTM)
- $0.61
- Revenue (LTM)
- $17.3B
- Net margin
- 4.08%
Nomior Score
66
Steady ProfileTop 14% of the scored universe
Growth52
Quality54
Value54
Momentum96
Resilience46
Growth
−2.61%revenue a year over 9 fiscal years
YE16 $21.9BLTM $17.3B
Connections
Revenue to profitQ2 YE26
The operating loss was 6% of revenue, wider by 16 pts on a year.